Intracerebroventricular metformin attenuates salt-induced hypertension in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 14, Issue 11 I, 2001, Pages 1116-1122

  Petersen, Jørgen Søberg ^a,d   Andersen, Ditte ^a   Muntzel, Martin S ^b   Diemer, Nils Henrik ^c   Holstein Rathlou, Niels Henrik ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Zealand Pharma AS   (Denmark)

Author keywords

Blood pressure; Hypertension; Metformin; Sympathetic nerve activity

Indexed keywords

HEXAMETHONIUM; METFORMIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFECT; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HEART RATE VARIABILITY; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SALT INTAKE; SYMPATHETIC BLOCKING;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYPERTENSION; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENTRICULAR; MALE; METFORMIN; RATS; RATS, INBRED SHR; SODIUM CHLORIDE, DIETARY; TREATMENT OUTCOME;

EID: 0034755024     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02220-8     Document Type: Article

References (36)

1. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats
2. Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats
3. Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas
4. Efficacy of the long-term metformin in hyperlipidaemic patients
5. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment
6. Metformin in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
7. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors
8. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women
9. Metformin for obese, insulin-treated diabetic patients: Improvement in glycaemic control and reduction of metabolic risk factors
10. Metabolic and hemodynamic effects of metformin and glibenclamid in normotensive NIDDM patients
11. Oral antidiabetic combination therapy with sulphonylureas and metformin
12. Metformin attenuates salt-induced hypertension in spontaneously hypertensive rats
13. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance
14. Acute sympathoinhibitory action of metformin in spontaneously hypertensive rats
15. Metformin inhibits ganglionic neurotransmission in renal nerves
16. Effects of adrenergic, cholinergic and ganglionic blockade on acute depressor responses to metformin in spontaneously hypertensive rats
17. Effects of central metformin administration on responses to air jet stress and on arterial baroreflex function in spontaneously hypertensive rats
18. Cardiovascular actions of chronic intracerebroventricular administration of metformin in normotensive rats
19. Effect of sinoaortic deafferentiation on renal wrap hypertension
20. Renal blood flow autoregulation: A case study in nonlinear dynamics
21. Hemodynamic analysis of arterial pressure oscillations in conscious rats
22. Spectrum analysis of sympathetic nerve activity and blood pressure in conscious rats
23. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients
24. The effects of metformin on the metabolic abnormalities associated with upper-body fat distribution
25. The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes
26. Relationship between sodium-lithium countertransport and insulin sensitivity in mild hypertension
27. Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity
28. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance
29. The effect of metformin on blood pressure and metabolism in nondiabetic hypertensive patients
30. Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives
31. The effect of metformin in glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus
32. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations
33. The effect of metformin insulin on sympathetic nerve activity norepinephrine spillover blood pressure in obese insulin resistant normoglycemic hypertensive men
34. Metformin and metoprolol CR treatment in non-obese men
35. Sensory circumventricular organs and brain homeostatic pathways
36. Cranial CT findings in metformin (Glucophage)-induced lactic acidosis